首页 | 官方网站   微博 | 高级检索  
     

艾迪注射液的化学成分研究
引用本文:张苗苗,刘艳丽,陈重,李笑然,许琼明,杨世林.艾迪注射液的化学成分研究[J].中草药,2012,43(8):1462-1470.
作者姓名:张苗苗  刘艳丽  陈重  李笑然  许琼明  杨世林
作者单位:苏州大学药学院,江苏苏州,215123
基金项目:重大新药创制国家科技重大专项资助项目(2009ZX09308-003,2011ZX09201-201-16)
摘    要:目的 研究艾迪注射液的化学成分.方法 利用反相半制备液相色谱、Sephadex LH-20凝胶柱色谱等方法分离纯化,并通过光谱数据鉴定化合物结构.结果 分离得到22个化合物,分别鉴定为3-O-(3′,4′-二乙酰氧基)-β-D-吡喃木糖基-6-O-β-D-吡喃葡萄糖基-环黄芪醇(1)、黄芪甲苷(2)、黄芪皂苷Ⅱ (3)、黄芪皂苷Ⅰ(4)、异黄芪皂苷Ⅰ(5)、乙酰黄芪皂苷Ⅰ(6)、人参皂苷Re (7)、人参皂苷Rf(8)、人参皂苷Rg1 (9)、人参皂苷Rb3 (10)、三七皂苷R4 (11)、人参皂苷Rb1 (12)、人参皂苷Rc (13)、人参皂苷Rb2 (14)、人参皂苷Rd (15)、丝瓜苷H(16)、3-O-β-D-吡喃葡萄糖基(1→4)-β-D-吡喃葡萄糖基(1→3)-α-L-吡喃鼠李糖(1→2)-α-L-吡喃阿拉伯糖-齐墩果酸-28-O-α-L-吡喃鼠李糖(1→4)-β-D-吡喃葡萄糖(1→6)-β-D-吡喃葡萄糖酯苷(17)、3-O-β-D-吡喃葡萄糖基(1→3)-α-L-吡喃鼠李糖β-D-吡喃葡萄糖基-(1→4)]-(1→2)-α-L-吡喃阿拉伯糖-齐墩果酸-28-O-α-L-吡喃鼠李糖(1→4)-β-D-吡喃葡萄糖(1→6)-β-D-吡喃葡萄糖酯苷(18)、紫丁香苷(19)、刺五加皂苷E(20)、4-(1,2,3-三羟基丙基)-2,6-二甲氧基苯-1-O-β-D-葡萄糖苷(21)、松柏苷(22).结论 经LC-MS分析检测,化合物1~6为黄芪中的化学成分,化合物7~18为人参中的化学成分,化合物19~22为刺五加中的化学成分,其中化合物1为新化合物,命名为新黄芪皂苷Ⅰ.

关 键 词:艾迪注射液  新黄芪皂苷Ⅰ  3-O-(3′  4′-二乙酰氧基)-β-D-吡喃木糖基-6-O-β-D-吡喃葡萄糖基-环黄芪醇  丝瓜苷H  LC-MS分析
收稿时间:4/5/2012 12:00:00 AM

Studies on chemical constituents from Aidi Injection
ZHANG MiaoMiao,LIU YanLi,CHEN Zhong,LI XiaoRan,XU QiongMing and YANG ShiLin.Studies on chemical constituents from Aidi Injection[J].Chinese Traditional and Herbal Drugs,2012,43(8):1462-1470.
Authors:ZHANG MiaoMiao  LIU YanLi  CHEN Zhong  LI XiaoRan  XU QiongMing and YANG ShiLin
Affiliation:College of Pharmacy,Soochow University,Suzhou 215123,China
Abstract:Objective To investigate the chemical constituents from Aidi Injection.Methods The chemical constituents were isolated by chromatography on Sephadex LH-20 gel columns and reverse phase semi-preparation HPLC repeatedly,and their structures were identified by spectral data.Results Twenty-two compounds were isolated and identified as 3-O-(3′,4′-diacetyl)-β-Dxylopyranosyl-6-O-β-D-glucopyranosyl-cycloastragenol(1),astragaloside IV(2),astragaloside II(3),astragaloside I(4),isoastragaloside I(5),acetylastragaloside I(6),ginsenosid-Re(7),ginsenoside-Rf(8),ginsenoside-Rg1(9),ginsenoside-Rb3(10),notoginsenoside-R4(11),ginsenoside-Rb1(12),ginsenoside-Rc(13),ginsenoside-Rb2(14),ginsenoside-Rd(15),lucyoside H(16),3-O-β-D-glucopyranosyl(1→4)-β-D-glucopyranosyl(1→3)-α-L-rhamnopyranosyl(1→2)-α-L-arabinopyranosyl oleanolic acid 28-Oα-L-rhamnopyranosyl(1→4)-β-D-glucopyranosyl(1→6)-β-D-glucopyranoside(17),3-O-β-D-glucopyranosyl(1→3)-α-L-rhamnopyranosyl β-D-glucopyranosyl-(1→4)]-(1→2)-α-L-arabinopyranosyl oleanolic acid 28-O-α-L-arabinopyranosyl(1→4)-β-D-glucopyranosyl(1→6)-β-D-glucopyranoside(18),syringin(19),elentheroside E(20),4-(1,2,3-trihydroxypropyl)-2,6-dimethoxyphenyl1-O-β-D-glucopyranoside(21),and coniferin(22).Conclusion LC-MS analysis shows that compounds 1—6 are originated from Astragalus membranceus,compounds 7—18 from Panax ginseng,and compounds 19—22 from Acanthopanacis senticosi.Compound 1 is a new compound named neoastragaloside I.
Keywords:Aidi Injection  neoastragaloside I  3-O-(3′  4′-diacetyl)-β-D-xylopyranosyl-6-O-β-D-glucopyranosyl-cycloastragenol  lucyoside H  LC-MS analysis
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中草药》浏览原始摘要信息
点击此处可从《中草药》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号